Rabbit Anti-Human IRF7 Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-PI3K p110 delta (Poly6049) Polyclonal Antibody, Unconjugated from BioLegend
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human CD164 Antibody, Biotin Conjugated from BioLegend
Biology Products:... have a conversation with someone, we not only hea...older or twinkle. Gazes can be direct or shifty. “... meaning to the words we hear. , In a report to be...Autism Research in Seatlle, researchers from UCLA ... They hear and they see, of course, but the areas ...
...ity of Florida researchers have revealed how the i...es and prevents immune cells from reaching the sit...01 when letters containing the bacteria,s spores w...hed last week in the EMBO Journal, may lead to qui...se causes flu-like symptoms that can take weeks to...
...wing premature birth rate in the United States app...of pesticides and nitrates, according to work cond...cal pediatrics at the Indiana University School of...diatric Academic Societies, annual meeting, a comb...the Society for Pediatric Research, the Ambulatory...
Other Biology News:A frown or a smile? Children with autism can't discern 2Anthrax paralyzes immune cells with lethal toxin, UF research shows 2Anthrax paralyzes immune cells with lethal toxin, UF research shows 3Premature births may be linked to seasonal levels of pesticides and nitrates in surface water 2(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-First...e global specialty biopharmaceutical company, toda...opean Medicines Agency for,velaglucerase alfa, the...nt,for the treatment of Type 1 Gaucher disease. Th...erase alfa that has been submitted, with previous,...
(Date:11/24/2009)... , REDWOOD CITY, Calif., Nov. 24 /PRNewswir...X ) today announced that Randy Scott, Genomic Heal...Annual Piper Jaffray Health Care Conference in New....m. ET. ,, To access the live and subsequently...nvestor Relations section of Genomic Health,s webs...
(Date:11/24/2009)... Program Connects Customers w...les Collected with DNA Genotek Products , ...009 -- DNA Genotek , a leading provider of produc... and preparation, today announced its new global p...ancements for DNA Genotek,s partner community and ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3